NUVL
Nuvalent, Inc.NASDAQHealthcare$105.43-0.20%ClosedMarket Cap: $7.72B
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
6.34
P/S
0.00
EV/EBITDA
-22.05
DCF Value
$3.22
FCF Yield
-3.6%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-42.1%
ROA
-30.1%
ROIC
-31.4%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $0.00 | NaN% | $-102.2M | $-118.7M | $-1.58 | — |
| FY 2025 | $0.00 | NaN% | $-414.3M | $-425.4M | $-5.85 | — |
| Q3 2025 | $0.00 | NaN% | $-112.7M | $-122.4M | $-1.70 | — |
| Q2 2025 | $0.00 | NaN% | $-104.6M | $-99.7M | $-1.39 | — |
| Q1 2025 | $0.00 | NaN% | $-94.8M | $-84.6M | $-1.18 | — |
| Q4 2024 | $0.00 | NaN% | $-86.3M | $-74.8M | $-1.05 | — |
| FY 2024 | $0.00 | NaN% | $-280.4M | $-260.8M | $-3.93 | — |
| Q3 2024 | $0.00 | NaN% | $-76.3M | $-84.3M | $-1.28 | — |
| Q2 2024 | $0.00 | NaN% | $-65.2M | $-57.2M | $-0.88 | — |
| Q1 2024 | $0.00 | NaN% | $-52.6M | $-44.5M | $-0.69 | — |
| Q4 2023 | $0.00 | NaN% | $-46.4M | $-38.3M | $-0.62 | — |
| FY 2023 | $0.00 | NaN% | $-149.5M | $-126.2M | $-2.17 | — |